Preventive effects of 13 different drugs on colorectal cancer: a network meta-analysis.
chemical prevention
colorectal cancer
drug intervention
network meta-analysis
Journal
Archives of medical science : AMS
ISSN: 1734-1922
Titre abrégé: Arch Med Sci
Pays: Poland
ID NLM: 101258257
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
03
2023
accepted:
06
06
2023
medline:
21
9
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
epublish
Résumé
The aim of the study was to evaluate the preventive effect of 13 drugs on colorectal cancer (CRC) and guide the clinical application of these drugs. PubMed, Web of Science, Embase, Cochrane Library, and China National Knowledge Infrastructure were searched for randomized controlled trials (RCTs) and cohort studies. The Cochrane bias risk assessment tool and the Newcastle-Ottawa Scale quality evaluation tool were used to evaluate the quality of the included RCTs and cohort studies. The funnel plot was used to analyze publication bias. A network meta-analysis of the extracted data was conducted using Stata16.0 software. A total of 57 studies (34 RCTs and 23 cohort studies) involving 82719 participants were included. The network meta-analysis revealed that the quality of the included studies was good; the funnel plot showed no obvious publication bias. The network meta-analysis showed that the preventive effect of 13 drugs on CRC was better than that of the placebo. Allopurinol (SUCRA: 97.2%) was found to have the best effect, followed by berberine (SUCRA: 89.9%), non-aspirin NSAIDs (SUCRA: 84.5%), statins (SUCRA: 66.5%), metformin (SUCRA: 66.3%), calcium (SUCRA: 48.9%), mesalazine (SUCRA: 44.5%), ursodeoxycholic acid (SUCRA: 42.6%), vitamin D (SUCRA: 41.4%), mercaptopurine (SUCRA: 39.4%), aspirin (SUCRA: 30.4%), folic acid (SUCRA: 24.9%), and eicosapentaenoic acid (SUCRA: 16.3%). The preventive effect of allopurinol on CRC was better than that of the other 13 drugs. These results can help doctors and patients understand the preventative effects of these drugs more intuitively and provide an evidence-based basis for the clinical application of these drugs.
Identifiants
pubmed: 37732038
doi: 10.5114/aoms/167480
pii: 167480
pmc: PMC10507769
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1428-1445Informations de copyright
Copyright: © 2023 Termedia & Banach.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Cancer Causes Control. 2019 Jun;30(6):637-649
pubmed: 30963391
Support Care Cancer. 2016 Apr;24(4):1655-61
pubmed: 26408324
Gut. 2015 Oct;64(10):1637-49
pubmed: 26041752
Cancer Med. 2014 Oct;3(5):1458-66
pubmed: 25091592
J Clin Pharmacol. 2021 Aug;61(8):1131-1137
pubmed: 33580545
Cancer Causes Control. 2021 Oct;32(10):1047-1061
pubmed: 34224060
Nat Rev Cancer. 2014 May;14(5):342-57
pubmed: 24705652
J Ethnopharmacol. 2022 Jan 10;282:114617
pubmed: 34509605
Lancet Oncol. 2016 Apr;17(4):475-483
pubmed: 26947328
Nat Rev Cancer. 2003 Aug;3(8):601-14
pubmed: 12894248
World J Gastroenterol. 2014 Feb 21;20(7):1858-70
pubmed: 24587664
N Engl J Med. 2002 Apr 4;346(14):1054-9
pubmed: 11932472
Cancer Causes Control. 2002 Apr;13(3):213-20
pubmed: 12020102
Anticancer Res. 2004 Sep-Oct;24(5B):3121-7
pubmed: 15510599
Int J Colorectal Dis. 2007 Jul;22(7):765-76
pubmed: 17216221
Biofactors. 2009 May-Jun;35(3):266-72
pubmed: 19391122
Int J Cancer. 2016 Nov 15;139(10):2232-42
pubmed: 27466215
Br J Cancer. 2013 Jul 9;109(1):249-56
pubmed: 23778525
J Nutr Biochem. 2003 May;14(5):246-50
pubmed: 12832027
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1877-83
pubmed: 23966577
Aliment Pharmacol Ther. 2017 Feb;45(4):533-541
pubmed: 27995656
Curr Pharm Des. 2007;13(22):2274-82
pubmed: 17692000
N Engl J Med. 2015 Oct 15;373(16):1519-30
pubmed: 26465985
Ann Intern Med. 2001 Jan 16;134(2):89-95
pubmed: 11177311
Intern Emerg Med. 2017 Feb;12(1):103-111
pubmed: 27913917
J Natl Cancer Inst. 2007 Jan 17;99(2):129-36
pubmed: 17227996
Gut. 2010 May;59(5):622-9
pubmed: 20427397
Cancer Epidemiol. 2019 Feb;58:52-62
pubmed: 30472477
Inflamm Bowel Dis. 2013 Jul;19(8):1631-8
pubmed: 23665966
Br J Cancer. 2012 Apr 10;106(8):1374-8
pubmed: 22421948
Turk J Gastroenterol. 2021 Nov;32(11):988-994
pubmed: 34872900
Practitioner. 2011 Dec;255(1746):17-20, 2-3
pubmed: 22272526
Lancet Gastroenterol Hepatol. 2021 Jun;6(6):474-481
pubmed: 33812492
J Inherit Metab Dis. 2011 Feb;34(1):101-9
pubmed: 20544289
Res Synth Methods. 2013 Dec;4(4):291-323
pubmed: 26053945
Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G7-17
pubmed: 15194558
BMC Med Res Methodol. 2014 Apr 01;14:45
pubmed: 24690082
Exp Cell Res. 1996 Jan 10;222(1):179-88
pubmed: 8549662
Transl Res. 2018 Jun;196:42-61
pubmed: 29421522
Aliment Pharmacol Ther. 2017 May;45(9):1179-1192
pubmed: 28261835
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2136-45
pubmed: 18708408
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Pharmacol Rev. 2012 Jan;64(1):102-46
pubmed: 22106090
Gastroenterology. 2008 Jan;134(1):29-38
pubmed: 18022173
Gac Sanit. 2015 Nov-Dec;29(6):464-71
pubmed: 26341155
Clin Gastroenterol Hepatol. 2006 Nov;4(11):1346-50
pubmed: 17059900
J Natl Cancer Inst. 2009 Feb 18;101(4):267-76
pubmed: 19211442
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):267-275
pubmed: 31926918
Aliment Pharmacol Ther. 2012 Feb;35(4):451-7
pubmed: 22221173
Nutrients. 2021 Jan 12;13(1):
pubmed: 33445534
Curr Pharmacol Rep. 2015 Oct 1;1(5):295-301
pubmed: 26688785
Int J Cancer. 2019 Feb 1;144(3):448-458
pubmed: 30117164
Leukemia. 2002 Apr;16(4):508-19
pubmed: 11960327
Nutrients. 2019 Jan 14;11(1):
pubmed: 30646512
Lancet. 2000 Oct 14;356(9238):1300-6
pubmed: 11073017
Int J Oncol. 2003 Oct;23(4):1055-69
pubmed: 12963986
Cancer. 2015 Apr 1;121(7):1071-8
pubmed: 25424411
Dig Dis Sci. 2010 Jun;55(6):1696-703
pubmed: 19705280
Gastroenterology. 2006 Dec;131(6):1674-82
pubmed: 17087947
BMJ. 2005 Jun 4;330(7503):1304-5
pubmed: 15849206
Arch Med Sci. 2023 Jan 13;19(1):264-269
pubmed: 36817685
Cell. 2007 Feb 23;128(4):683-92
pubmed: 17320506
Nutr Cancer. 2005;51(1):110-6
pubmed: 15749637
Ann Intern Med. 2013 Jul 16;159(2):130-7
pubmed: 23856683
Aliment Pharmacol Ther. 2010 Apr;31(7):708-18
pubmed: 20085565
Gut. 2014 Nov;63(11):1755-9
pubmed: 24488498
Adv Nutr. 2012 Jan;3(1):21-38
pubmed: 22332098
J Insur Med. 2017;47(2):65-94
pubmed: 29490155
BMC Cancer. 2008 Aug 14;8:237
pubmed: 18702823
Arch Med Sci. 2021 Mar 24;18(5):1221-1230
pubmed: 36160343
Int J Colorectal Dis. 2021 Aug;36(8):1711-1722
pubmed: 33682036
Cancer Prev Res (Phila). 2013 Jul;6(7):744-52
pubmed: 23682073
Int J Epidemiol. 2016 Jun;45(3):940-53
pubmed: 27063605
J Natl Cancer Inst. 2005 Jun 1;97(11):846-53
pubmed: 15928305
Clin Lab. 2011;57(9-10):741-7
pubmed: 22029190
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2353-8
pubmed: 16214916
Cancer Med. 2013 Feb;2(1):50-6
pubmed: 24133627
Cancer Prev Res (Phila). 2013 Feb;6(2):74-81
pubmed: 23213070
Oncotarget. 2015 Oct 13;6(31):32013-26
pubmed: 26397137
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Cell Cycle. 2004 Jul;3(7):931-40
pubmed: 15190207
Mol Cell Endocrinol. 2006 Mar 27;248(1-2):149-59
pubmed: 16406653
Front Physiol. 2018 Jul 31;9:1039
pubmed: 30108523
Pharmacol Rev. 2006 Mar;58(1):87-114
pubmed: 16507884
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):752-6
pubmed: 17223551
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33
pubmed: 19755647
Aliment Pharmacol Ther. 2014 Dec;40(11-12):1341-8
pubmed: 25278035
Am J Epidemiol. 2010 Sep 1;172(5):489-500
pubmed: 20650953
JAMA. 2007 Jun 6;297(21):2351-9
pubmed: 17551129
Int J Cancer. 2012 Aug 1;131(3):752-9
pubmed: 21913184
Inflamm Bowel Dis. 2007 Apr;13(4):367-71
pubmed: 17206695
Gastroenterology. 2003 Apr;124(4):889-93
pubmed: 12671884
Int J Cancer. 2011 Jul 1;129(1):192-203
pubmed: 21170989
Clin Nutr. 2020 Aug;39(8):2525-2538
pubmed: 31784301
Lancet. 2011 Dec 17;378(9809):2081-7
pubmed: 22036019
N Engl J Med. 2003 Mar 6;348(10):891-9
pubmed: 12621133
Gut. 2021 Mar;70(3):555-566
pubmed: 32641470
Digestion. 2009;79(1):17-22
pubmed: 19246916
Int J Colorectal Dis. 2013 Apr;28(4):469-76
pubmed: 23114474
Swiss Med Wkly. 2001 Sep 22;131(37-38):539-49
pubmed: 11759174
Diabetes Care. 2010 Feb;33(2):322-6
pubmed: 19918015
Lancet. 2018 Dec 15;392(10164):2583-2594
pubmed: 30466866
PLoS One. 2018 Feb 9;13(2):e0192223
pubmed: 29425227
Aliment Pharmacol Ther. 2005 Nov 1;22(9):783-8
pubmed: 16225486
Aliment Pharmacol Ther. 2000 Feb;14(2):145-53
pubmed: 10651654
Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1364-73
pubmed: 23753040
Clin Gastroenterol Hepatol. 2005 Oct;3(10):1015-21
pubmed: 16234048